Skip to main content
Carlos Subauste, MD, Infectious Disease, Cleveland, OH, University Hospitals Cleveland Medical Center

CarlosSubausteMD

Infectious Disease Cleveland, OH

Professor, Medicine and Pathology, Case Western Reserve University School of Medicine

Dr. Subauste is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Subauste's full profile

Already have an account?

  • Office

    UH Cleveland Medical Center
    11100 Euclid Ave Department of Medicine-Infectious Diseases & HIV Medicine
    Cleveland, OH 44106
    Phone+1 216-844-7892
    Fax+1 216-368-2034
  • Is this information wrong?

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 1988 - 1992
  • Southern Illinois University
    Southern Illinois UniversityResidency, Internal Medicine, 1984 - 1987
  • Cayetano Heredia University
    Cayetano Heredia UniversityClass of 1983

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1988 - Present
  • OH State Medical License
    OH State Medical License 1997 - 2026
  • IL State Medical License
    IL State Medical License 1984 - 1990
  • American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Journal Articles

  • Disruption of retinal inflammation and the development of diabetic retinopathy in mice by a CD40-derived peptide or mutation of CD40 in Müller cells  
    Jose-Andres C Portillo, Jin-Sang Yu, Sarah Vos, Reena Bapputty, Yalitza Lopez Corcino, Alyssa Hubal, Jad Daw, Sahil Arora, Wenyu Sun, Zheng-Rong Lu, Carlos S Subauste, Diabetologia, 8/3/2022

Press Mentions

  • Scientists Find Therapeutic Target for Diabetes-Related Blindness
    Scientists Find Therapeutic Target for Diabetes-Related BlindnessMarch 8th, 2017

Hospital Affiliations